← Eichor
Condition: Veno Occlusive Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Veno Occlusive Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment
Phase 4 · 1 location(s) · First Affiliated Hospital of Chongqing Medical University · NCT07133438Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathie
NA · 1 location(s) · CHU de Reims · NCT03680794Non-invasive Venous Air Plethysmography Assessment of Venous Hemodynamics in Patients Suspected Deep Venous Obstruction
Phase N/A · 1 location(s) · Mayo Clinic · NCT06519435Effect of Video Viewing on Intravitreal Injection Experience
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07002372Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab
Phase N/A · 1 location(s) · Ataturk University · NCT07550777Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplant
Phase N/A · 2 location(s) · University of Turin, Italy · NCT06715046RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-UK)
NA · 1 location(s) · Intervene, Inc. · NCT07219758Central Vein Stenosis Due to Dialysis Catheter Insertion in Subclavian Compared to Jugular Vein
NA · 1 location(s) · Skane University Hospital · NCT04871568Free for Weaning ECMO vs Respiratory Driven Study
NA · 4 location(s) · Assistance Publique Hopitaux De Marseille · NCT06876415RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)
NA · 1 location(s) · Intervene, Inc. · NCT07095660The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
NA · 27 location(s) · W.L.Gore & Associates · NCT05489588The Solaris DE Endoprosthesis for the Treatment of AV Access Stenosis or Occlusion
NA · 5 location(s) · Scitech Produtos Medicos SA · NCT06096142Efficacy and Safety Evaluation of SMO1 in Patients With Retinal Vein Occlusive Macular Edema
Phase 3 · 1 location(s) · SANGMYUNG innovation · NCT07708142Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting
NA · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT04694248A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Phase 2 · 49 location(s) · EyeBiotech Ltd. · NCT07205887Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion
Phase 2 · 1 location(s) · Annexin Pharmaceuticals AB · NCT07259928Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
NA · 1 location(s) · Johns Hopkins University · NCT04505618Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
EARLY_Phase 1 · 1 location(s) · MediBeacon · NCT04008121Investigation of a New Window Into Intracranial Pressure: Venous Occlusion Pressure of the Isolated Periorbital Vein
NA · 1 location(s) · University of Freiburg · NCT07053631WRAP North America
Phase N/A · 16 location(s) · Merit Medical Systems, Inc. · NCT06807099National Eye Institute Biorepository for Retinal Diseases
Phase N/A · 1 location(s) · National Eye Institute (NEI) · NCT01496625Defibrotide Dose-escalation for SOS Post-HSCT
Phase 2 · 1 location(s) · New York Medical College · NCT05987124DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. Th
Phase N/A · 1 location(s) · Bayer · NCT07308639
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.